Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mary C. Bibro is active.

Publication


Featured researches published by Mary C. Bibro.


Cancer | 1982

Benign clinical behavior of immature mediastinal teratoma in infancy and childhood: Report of two cases and review of the literature

Darryl Carter; Mary C. Bibro; Robert J. Touloukian

Germ cell tumors of the mediastinum can be divided into three categories: 1) mature teratomas which have all elements at a mature level; 2) immature teratomas which are similar to the mature teratomas, but also contain immature epithelial or mesenchymal elements or blastema; and 3) embryonal tumors which contain elements which are recognized as dysgerminoma, embryonal carcinoma with or without yolk sac elements, and choriocarcinoma. Immature teratomas are the rarest type, accounting for only about 1% of mediastinal teratomas. Two cases of immature teratoma of the mediastinum occurring in infants are reported. One tumor was completely excised. The child is well without evidence of disease two years later. The other immature teratoma was unresectable. Biopsy showed it to be similar to the teratoma that was excised. No postoperative treatment was given. The tumor has not changed appreciably in size, but the child has grown normally for six years so that the tumor mass, which initially filled his chest, is now evidenced as mediastinal widening. A review of the reported cases of immature teratomas in the mediastinum shows that the prognostic value of the histologic appearance of these tumors has not been developed to the same degree as it has for teratomas in the ovary or the sacrococcygeal region. The immature teratomas that occur in infants behave as mass lesions as do the mature teratomas. Immature teratomas in the mediastinum of children in their late teens and in young adults behave as highly malignant tumors similar to the embryonal carcinomas.


Gynecologic Oncology | 1987

Prognostic factors associated with radical hysterectomy failure

Thomas W. Burke; William J. Hoskins; Paul B. Heller; Mary C. Bibro; Edward B. Weiser; Robert C. Park

Two hundred seventy-five patients who underwent radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB carcinoma of the cervix between 1961 and 1982 were retrospectively analyzed to identify specific risk factors associated with treatment failure. Patients were classified as high or low risk on the basis of tumor spread to pelvic lymph nodes or surgical margins. Thirty-eight patients had tumor involvement of pelvic nodes or surgical margins. Despite postoperative whole pelvis radiation therapy in 88% of patients, 13 (34.2%) developed recurrence. All patients with involved nodes or margins who recurred died of disease. Patients with pelvic lymph node or surgical margin involvement clearly constitute a high risk group and should be considered candidates for some form of adjuvant therapy. Two hundred thirty-seven patients had negative nodes and clear surgical margins. There were 18 recurrences (7.6%) in this group. Pathologic specimens were reviewed to evaluate additional histologic criteria which might identify those patients at greatest risk for tumor recurrence in this low risk group. Patients whose tumors contained vascular-lymphatic space invasion or adenomatous histologic components recurred more frequently than patients whose tumors did not (P less than 0.05). Eighty-three percent of low risk patients who recurred had tumors with at least one of these features. Degree of differentiation and depth of invasion did not correlate with risk of recurrence. Prospective randomized trials are needed to determine the effectiveness of postoperative adjuvant therapy for patients at risk for recurrent disease.


Gynecologic Oncology | 1985

Radical hysterectomy and pelvic lymphadenectomy for Stage IB carcinoma of the cervix: 21 years experience

Lee E. Artman; William J. Hoskins; Mary C. Bibro; Paul B. Heller; Edward B. Weiser; D. Barnhill; Robert C. Park

From September 1971 through December 1982, 153 patients with Stage IB carcinoma of the cervix underwent radical hysterectomy and pelvic lymphadenectomy at two of the teaching hospitals of the Uniformed Services University of the Health Sciences. Records were retrospectively analyzed and independent pathologic review was performed. All surgical procedures were performed by fellows or senior residents under the direct supervision of the gynecologic oncology staff of the Walter Reed Army Medical Center or the Naval Hospital, Bethesda, Maryland. In this series, IB carcinoma was defined as squamous carcinoma clinically confined to the cervix with invasion greater than 5 mm from the basement membrane or any adenocarcinoma confined to the cervix. The average age of the patients was 38.3 years. The histologic types were squamous in 72%, adenocarcinoma in 16%, and adenosquamous in 10.5%. The mean operating time was 5 hr and 40 min with an average blood loss of 1800 cc. There were two ureterovaginal and two vesicovaginal fistulae for an overall fistula rate of 2.6%. Actuarial survival for these 153 patients is 84%. This extends the previous series of R. C. Park, W. E. Patow, R. E. Rogers, and E. A. Zimmerman, Obstet. Gynecol. 41, 117-122 (1973) of 122 cases collected from 1961 to September 1971 to 275 cases. In comparing the two time periods, no significant differences were found in operative technique or complications, but there was a change in the incidence of adenocarcinoma and mixed cell types and a difference in survival. A relatively higher incidence of more aggressive tumors may indicate the need for different therapeutic approaches in the future.


Cancer | 1984

Pulmonary blastoma. Case report and literature review of chemotherapy experience

Clinton A. Medbery; Mary C. Bibro; John C. Phares; Stephen R. Veach; James Martin; Dominick N. Pasquale

Pulmonary blastoma is a rare primary lung neoplasm, occurring in both children and adults, which is pathologically, clinically, and prognostically distinct from other lung tumors. Usually it has been treated with surgery, but both chemotherapy and radiotherapy have been used for metastatic disease, and in the adjuvant setting. A patient is described who presented with metastatic pulmonary blastoma. Treatment with cyclophosphamide, vincristine, doxorubicin, and dactinomycin resulted in an objective response as judged by standard criteria. The literature is reviewed for other experience with chemotherapy in this rare lung tumor. This four‐drug combination appears to show promise for tumor response, and is deserving of further trial.


Human Pathology | 1981

Elastofibroma dorsi: An immunochemical study of collagen content

Joseph A. Mardi; Craig A. Dise; Virginia A. LiVolsi; Maria J. Merino; Mary C. Bibro

The types of collagen present in a case of elastofibroma dorsi were determined using type specific, characterized collagen antibodies. The presence of type II collagen (normally present only in articular cartilage and in selected ocular structures) is discussed with regard to the pathogenesis of this lesion, and the use of collagen antibodies is discussed with regard to their potential value in better characterizing and classifying mesenchymal tumors.


Gynecologic Oncology | 1980

Squamous carcinoma of the endometrium with ultrastructural observations and review of the literature

Mary C. Bibro; Daniel S. Kapp; Virginia A. LiVolsi; Peter E. Schwartz

Abstract Epithelial malignancies of the endometrium are almost always adenocarcinomas. Up to 50%, though, contain foci of benign or malignant squamous epithelium; but a primary malignancy with only squamous differentiation is extremely rare. We present the 17th case with, for the first time, ultrastructural observation. The tumor, confined to the fundus, was composed of sheets of squamous cells with focal pearl formation. Ultrastructural examination of the curettings revealed tonofilaments and keratohyaline granules characteristic of squamous cells, but failed to reveal attempts at luminae or acinar formation, or microvilli. The literature to date is reviewed with comments on prognosis, treatment, and histogenesis.


Obstetrics & Gynecology | 1985

Hidradenitis suppurativa: a case presentation and review of the literature.

Ronald L. Thomas; D. Barnhill; Mary C. Bibro; William J. Hoskins


American Journal of Clinical Pathology | 1979

Adenosarcoma of the Uterus: Ultrastructural Observations

Mary C. Bibro; Virginia A. LiVolsi; Peter E. Schwartz


Obstetrics & Gynecology | 1986

Histiocytosis-X in gynecology: a case presentation and review of the literature.

Ronald L. Thomas; Danny Barnhill; Mary C. Bibro; William J. Hoskins; William Hambidge


International Journal of Radiation Oncology Biology Physics | 1980

Pretreatment histopathological virulence factors in radiationtherapeutically managed carcinoma of the uterine cervix

Daniel S. Kapp; Mary C. Bibro; Roberta Lawrence; Peter E. Schwartz

Collaboration


Dive into the Mary C. Bibro's collaboration.

Top Co-Authors

Avatar

William J. Hoskins

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. Barnhill

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Edward B. Weiser

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Paul B. Heller

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert C. Park

Walter Reed Army Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lee E. Artman

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar

Ronald L. Thomas

Allegheny General Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge